ILS yields 8.16% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, ILS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ILS + PFE for your $10,000?
ILS is the first US-listed catastrophe bond ETF. It provides investors exposure to a non-correlated asset class through an actively managed portfolio of global catastrophe bonds. Catastrophe bonds, also known as Cat bonds, are financial instruments that transfer natural risk disasters from insurers to capital market investors. Insurers gain extra insurance protection while investors gain access to high yield returns. The fund exclusively holds high yield rated Cat bonds tied to natural disasters, called trigger events. These bonds may be issued by US and foreign insurers, reinsurers, governments, and special purpose vehicles (SPVs). It has no limit on the maturity of the securities, as well as to the type of natural catastrophes, geographic areas, or thresholds of economic or physical loss it can invest in. In selecting constituents, qualitative and quantitative elements are considered including peril type, geography, payout trigger, issuer, and risk-adjusted return potential.
Full ILS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.